BEST EBs FOR HEALTHCARE LONDON?
Hi guys,
Curious to know the best EBs for healthcare in London? And EB HC Rankings Ldn?
Thanks a lot!
Trending Content - Investment Banking Forum
| +160 | As Lehman people reconvene at UBS, Barclays needs to hire (2023) | 23 | 6h |
| +126 | Is pay at BofA really that bad? | 62 | 2h |
| +88 | Day at Macquarie | 12 | 23h |
| +57 | Worlds Worst MDs Competition (2026 Edition) | 11 | 35m |
| +45 | How bad did I mess up | 10 | 1d |
| +44 | Is the life of a VP at a 'top-bank' really good? | 15 | 3d |
| +31 | Misrepresented Houston IB | 14 | 1d |
| +29 | No BB RO 2026 | 10 | 2d |
| +28 | JPM SMALL CAP or WF/JEF/RBC Coverage group | 13 | 20h |
| +24 | T(ouse)D Securities | 9 | 2d |
Career Resources
Interested too
Bear in mind PJT/CVP/Moelis are generalist whilst EVR/PWP have dedicated industry groups
Evercore
Lazard
Have heard Lazard is top notch in the area. Also Rothschild's HC team is supposed to be their strongest team so I am guessing they are strong in the HC field too.
Thank you guys for inputting so far.
RC very strong for sure. Interested in hearing more about deal size, as far as I am aware RC v good for volume. IK CVP and PJT dominate biopharma mega deals in US. Interested in hearing about UK/Europe from a HC mega deal perspective too
Quick overview of Europe:
Evercore's pretty decent - they did AstraZeneca / Alexion + a few other deals, fair mix between sell and buy sides.
CVP is good for biotech sell sides (in the US), they were also involved in AstraZeneca / Alexion + I think they're trying to replicate that franchise here in Europe. They've been involved in a sell sides here.
Not sure why you mentioned PJT here - not sure what they do here in Europe. (AbbVie / Allergan doesn't count even though Allergan is "Irish")
Rothschild and Jefferies are volume shops - predominately PE sell sides. Quick Linkedin search of their profiles and you'd realize they have relatively better PE exits than the aforementioned 3 shops
From Mergermarket (excluding the BBs, Big4 and MM players, including the generally accepted "EBs" + Jefferies), Target / Acquirer: Europe, Date: 01/01/19 - 14/2/21 (sorted by deal size)
1. Evercore
2. PJT
3. CVP
4. Roths
5. Lazard
6. Jefferies
7. Moelis
Amazing great stuff - cheers for the info!
Wouldn’t care about groups too much if considering exits as well, Lazard should be towards the top (probably the best overall brand name of the set), and Jefferies last
Wasn't EVR on the buy-side on those deals if I recall? i.e. less fees - how are they number 1?
I think this is very inaccurate...
CVP was on the sell-side of most the mega deals this year. One of their partners, Richard Girling (London partner) is a beast in HC . Also Rothschild and Laz did way better than EVR this year as well.
Dont know much about the rest so can't comment, but EVR as number 1 in London is a joke... Yes they're respected, did a lot better in 2019 than this year, but definitely not number one, they did poor from a fee perspective.
PJT done some big HC deals in London over the last few years. GSK / Tesaro deal and one with Novartis I think
Et consequatur deleniti animi et adipisci. Esse quia omnis architecto. Quae sunt commodi rerum aut vel non. Consequatur dolorem sint qui recusandae voluptatem voluptas tenetur. Architecto beatae ad cumque est praesentium omnis.
Sit est consequatur quibusdam voluptatum consequatur. Laudantium nihil eveniet optio possimus iusto. Omnis nisi ab cum quaerat. Odit laudantium reprehenderit debitis. Voluptates est repellat excepturi sequi.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...